Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 9 · below the Ichimoku cloud · RSI 55 · MACD above its signal · 10% below its 52-week high
None of the 29 investors followed here reported a position in 2607.HK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a 2607.HK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for 2607.HK.
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Buy / hold / sell counts
No recent headlines.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.8 | -2.1 | -0.9 | 1.8 | -3.5 | 0.4 | 5.4 | -5.5 | -2.5 | 1.0 | −1.4% | ||
| 2025 | -2.1 | -4.7 | -4.9 | -5.2 | 7.3 | 2.6 | 7.2 | -1.5 | -0.6 | -4.6 | 0.9 | -3.9 | −10.1% |
| 2024 | -3.3 | 14.1 | -10.3 | -1.4 | 4.1 | 1.2 | -0.2 | -7.8 | 17.4 | -5.4 | 8.3 | -2.9 | +10.5% |
| 2023 | 6.3 | 0.3 | 5.8 | 8.7 | -2.0 | -0.5 | -9.0 | -8.6 | -5.3 | -6.9 | -0.5 | 0.9 | −12.0% |
| 2022 | 2.7 | -7.2 | 7.2 | -15.5 | 0.2 | 1.7 | -9.1 | -3.2 | -5.2 | -1.8 | 21.6 | 0.3 | −12.2% |
| 2021 | -1.5 | 6.0 | 7.3 | 15.9 | -0.8 | -3.3 | -2.4 | -6.8 | -2.1 | -5.7 | -0.3 | 3.9 | +8.5% |
| 2020 | -4.2 | -1.8 | -7.6 | 3.6 | -10.2 | 6.2 | 5.7 | 0.4 | -6.2 | -7.4 | 9.3 | 3.8 | −10.2% |
| 2019 | 4.9 | 5.6 | -3.1 | -4.0 | -5.7 | -0.8 | -1.6 | -2.1 | -4.1 | -0.1 | -1.0 | 8.0 | −4.8% |
| 2018 | -3.1 | -3.8 | 6.5 | 2.6 | 12.5 | -10.7 | -3.9 | -1.0 | -5.0 | -11.5 | 11.4 | -17.5 | −24.7% |
| 2017 | 11.7 | 0.7 | 1.8 | 1.2 | 9.5 | 3.1 | -11.0 | -7.0 | -0.9 | 5.6 | -2.6 | 7.8 | +19.0% |
| 2016 | -11.2 | -6.0 | 9.4 | 7.7 | 1.7 | 1.8 | 7.7 | 15.8 | -1.9 | -4.3 | -3.0 | -8.4 | +6.0% |
| 2015 | -4.0 | -3.6 | 27.2 | 17.5 | 6.2 | -16.0 | -15.0 | -12.0 | 0.0 | 11.1 | -5.2 | -1.4 | −4.1% |
| 2014 | 1.3 | 5.1 | -12.7 | -19.5 | 2.7 | 10.6 | -10.5 | 10.3 | 19.4 | 2.3 | -4.8 | -5.3 | −7.8% |
| 2013 | 4.9 | 7.6 | 2.3 | -6.4 | -5.3 | -4.0 | 10.9 | -8.7 | 1.2 | 7.2 | 13.6 | 4.5 | +28.2% |
| 2012 | 2.1 | 12.3 | -13.7 | -6.1 | -19.3 | 2.5 | 13.8 | 20.4 | 8.6 | -0.1 | 1.1 | 1.9 | +17.6% |
| 2011 | 0.0 | 0.0 | 0.0 | 0.0 | 228400.0 | -8.3 | -17.4 | -6.4 | 3.5 | -10.6 | -4.3 | -12.3 | +125700.0% |
| 2010 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2009 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2008 | -31.2 | 9.1 | -41.7 | -14.3 | 0.0 | -66.7 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | −93.8% |
| 2007 | 26.0 | -18.1 | -87.8 | −87.4% |